World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Feb 14
Genetic function that could pave way for cancer therapies discovered
A team of researchers has discovered a genetic function that helps one of the most important "tumour suppressor" genes to do its job and prevent cancer.

According to scientists from OSU and Oregon Health and Science University, finding ways to maintain or increase the effectiveness of this gene - called Grp1-associated scaffold protein, or Grasp - could offer an important new avenue for human cancer therapies.

The Grasp gene was studied in the skin of mice in this research, but is actually expressed at the highest levels in the brain, heart and lung, studies have shown. It appears to play a fundamental role in the operation of the p53 tumour suppressor gene, which is a focus of much modern cancer research.

The new study has found that the Grasp gene is significantly involved in maintaining the proper function of p53. When "Grasp" is not being adequately expressed, the p53 protein that has entered the cell nucleus to either repair or destroy the cell comes back out of the nucleus before its work is finished.

"It appears that a primary function of Grasp is to form sort of a halo around the nucleus of a damaged skin cell, and act as kind of a plug to keep the p53 cell inside the nucleus until its work is done," one of the lead authors of this study Mark Leid said.

"A drug that could enhance Grasp function might also help enhance the p53 function, and give us a different way to keep this important tumour suppressor working the way that it is supposed to," the researcher added.

The study was published in the journal Photochemical and Photobiological Sciences.

Feb 14
Vitamin A rich diet essential for proper lung formation
In a significant breakthrough, the short-term deficit of vitamin A while the lungs are being formed in the baby during pregnancy has been linked to asthma later in life.

A team of Columbia University researchers has found the first direct evidence of a link between prenatal vitamin A deficiency and postnatal airway hyperresponsiveness - a hallmark of asthma.

The vitamin A deficiency can cause profound changes in the smooth muscle that surrounds the airways - causing the adult lungs to respond to environmental or pharmacological stimuli with excessive narrowing of airways, say Columbia University Medical Center (CUMC) investigators led by Wellington V. Cardoso.

"Researchers have long wondered what makes some people more susceptible than others to developing asthma symptoms when exposed to the same stimulus," added Cardoso, faculty member in the division of pulmonary allergy clinical care medicine.

Our study suggests that the presence of structural and functional abnormalities in the lungs due to vitamin A deficiency during development is an important and under-appreciated factor in this susceptibility, he stressed.

Previous studies had shown that retinoic acid (RA) - the active metabolite of vitamin A - is essential for normal lung development.

The researchers used a mouse model in which they could control when and in what amount vitamin A would reach the developing foetus through maternal diet.

They timed the vitamin A deficiency to the middle of gestation, coinciding with the period of formation of the airway tree in the foetus.

Foetuses that were deprived of vitamin A were found to have excess smooth muscle in the airways, compared with control groups.

In a subsequent experiment, the mice were again deprived of vitamin A during the same developmental stage, but returned to a normal diet after that stage and until adulthood.

"When the animals reached adulthood, they appeared normal; they had no problems typically associated with vitamin A deficiency," explained Cardoso.

However, pulmonary function tests showed that their lungs were clearly not normal.

When the mice were challenged with methacholine, a chemical that causes the airway to contract, their response was significantly more severe than that of controls.

The findings underscore the importance of sufficient vitamin A in the diet, which remains a significant challenge in developing countries, including India.

Feb 13
Being overweight can negatively affect memory, emotions and appetite
A new study has found that being overweight appears to be related to reduced levels of a molecule that reflects brain cell health in the hippocampus, a part of the brain involved in memory, learning, and emotions, and likely also involved in appetite control.

Jeremy D. Coplan, MD, professor of psychiatry at SUNY Downstate Medical Center, led a multicenter team that visualized the molecule, N-acetyl-aspartate (NAA), using magnetic resonance spectroscopy, a non-invasive magnetic resonance imaging (MRI) application.

NAA is associated with brain cell health. Overweight study participants exhibited lower levels of NAA in the hippocampus than normal weight subjects. The effect was independent of age, sex, and psychiatric diagnoses.

The importance of the hippocampus - a seahorse-shaped organ deep within the brain - to the formation and preservation of memory and to emotional control is well known, Dr. Coplan said, but its role in appetite control is less established.

"The relevance of the finding is that being overweight is associated with specific changes in a part of the brain that is crucial to memory formation and emotions, and probably to appetite," Dr. Coplan said.

The study is believed to be the first human research documenting the association of NAA with body weight.

"Whether low NAA is a consequence of being overweight, causes being overweight, or a combination of both remains to be determined," he added.

The findings are published in the journal Neuroimage: Clinical.

Feb 13
Moderate weight loss can help prevent, cure obstructive sleep apnea
A new study suggests that even a moderate weight reduction can prevent the progression of obstructive sleep apnea (OSA), and even cure it.

The study focused on the effects of weight loss on OSA and demonstrated, for the first time, that a sustained weight loss of just 5 percent was enough to prevent the disease from worsening and even cure it in a long-term follow-up.

Obstructive sleep apnea (OSA) has become a major burden for our health care systems over the last years.

Although it is one of the most increasingly prevalent non-communicable diseases, the vast majority of people with OSA still remain undiagnosed.

OSA has also been found to be tightly linked with metabolic abnormalities, particularly type 2 diabetes, and cardiovascular morbidity.

OSA is a chronic, progressive disease, and it is well-documented that moderate to severe forms of OSA are associated with an increased risk for cardiovascular morbidity and mortality. Obesity is the most important risk factor for OSA.

Based on current knowledge about the evolution of OSA, weight gain represents a high risk for the further progression of the disease towards the more severe forms, particularly in patients who already have a partial obstruction of their upper airways associated with mild OSA.

This study provides first time long-term evidence that even a modest weight reduction can result in marked improvements of OSA and metabolism in overweight patients, and these positive changes are sustained even four years after the cessation of the active intervention, and the progression of the disease is thus prevented.

The study is published in the journal Sleep Medicine.

Feb 10
78000 infants die of congenital heart disease in India every year: Doctors
According to a report by leading experts, it has been revealed that about 78,000 infants born with congenital heart disease in India die every year because of inadequate health care facilities.

In a medical camp,Dr Murtaza Chisti, Chief Cardiac Surgeon of the Mahatma Gandhi Cardiac and Critical Care Centre told that "Every year 1.5 lakh infants were born in India with congenital heart disease."

The acute lack of awareness and ignorance in people coupled with insufficient medical facilities have further pushed up the cases of congenital heart disease. And most of these children with such cases don't survive.

"Work-related tension coupled with changed lifestyle of young people that caused them to hurry and scurry for work had resulted in even people in the age group of 30 to 40 years get heart attacks or suffer from heart-related problems," he said.

"Controlled diet with less fatty and oily, and non-vegetarian food, non-consumption of sweets, coupled with adequate rest could reduce the incidence of heart problems.He enumerated diabetes, high blood pressure, mental tension, increase in cholesterol as the contributory causes for heart attacks.

Dr ML Swarankar, chairman of the India Education Trust, said that India had the dubious distinction of having the largest number of deaths in Asia owing to heart attack. More and well-equipped cardiac centres were needed to bring down the number, he added.

Feb 10
Reason behind hunger pangs revealed
Researchers have made a new breakthrough that could help explain why we feel hungry.

In this new paper, first authors Michael Krashes, PhD, and Bhavik Shah, PhD, postdoctoral fellows in the lab of Bradford Lowell , MD, PhD, Beth Israel Deaconess Medical Center (BIDMC) neuroendocrinologist, employed rabies circuit mapping, a technology in which a modified version of the rabies virus is engineered to "infect" just one type of neuron - in this case, the AgRP neurons that drive hunger.

The virus moves upstream one synapse and identifies all neurons that are providing input to AgRP starter neurons. Then, using a host of different neuron-specific cre-recombinase expressing mice (a group of genetically engineered animals originally developed in the Lowell lab) the investigators were able to map inputs to just these nerve cells, and then manipulate these upstream neurons so that they could be targeted

With this new information, the investigators now had a model to pursue.

Their results revealed that subsets of neurons expressing thyrotropin-releasing hormone (TRH) and pituitary adenylate cylcase-activating polypeptide (PACAP) were in on the neuronal chatter.

Finally, through a chemogenetic technique known as DREADDs - Designer Receptor Exclusively Activated by Designer Drug - the authors used chemicals to specifically and selectively stimulate or inhibit these upstream neurons in the animal models.

The fed mice, which had already consumed their daily meal and otherwise had no interest in food, proceeded to search out and voraciously eat after DREADD stimulation. Conversely, the fasting mice - which should have been hungry after a period of no food - ate very little when these upstream neurons were turned off.

The study has been published online in the journal Nature.

Feb 06
Too much salt ups obesity, inflammation risk in adolescents
Adolescents consuming more than twice the recommended daily allowance of salt increases their high sodium intake that correlates with fatness and inflammation regardless of how many calories they consume, a new study has found.

In the study of 766 healthy teens, 97 percent self-reported exceeding the American Heart Association's recommendation of consuming less than 1,500 milligrams of sodium daily.

"The majority of studies in humans show the more food you eat, the more salt you consume, the fatter you are," Dr. Haidong Zhu, molecular geneticist at the Medical College of Georgia and Institute of Public and Preventive Health at Georgia Regents University, said.

"Our study adjusted for what these young people ate and drank and there was still a correlation between salt intake and obesity," Zhu said.



These high-sodium consumers also had high levels of tumour necrosis factor alpha, which is secreted by immune cells and contributes to chronic inflammation as well as autoimmune diseases like lupus and arthritis.

Additionally, the adolescents had high levels of leptin, a hormone produced by fat cells that normally suppresses appetite and burns fat, but at chronically high levels can have the opposite effects.

"Losing weight is difficult, but hopefully more people can be successful at reducing their sodium intake," Zhu, the study's corresponding author, said.

Reductions would result from not automatically adding salt to food and choosing fresh fruits and vegetables over French fries and processed meats and snacks.

The study is published in the journal Pediatrics.

Feb 06
Mediterranean diet linked with lower risk of heart disease
A new research has revealed that greater adherence to Mediterranean-style diet was associated with lower risk factors for cardiovascular disease (CVD).

The study led by researchers from Harvard School of Public Health (HSPH) and Cambridge Health Alliance (CHA) is the first to assess the effects of Mediterranean-style diet among a group of young, working US adults.

"Our study adds more evidence showing the health benefits of a Mediterranean diet, even after adjusting for exercise and body weight," Stefanos Kales, associate professor in the Department of Environmental Health at HSPH and chief of occupational and environmental medicine at CHA, said.

US firefighters are known to have a high prevalence of obesity and risk factors for CVD. A Mediterranean diet, rich in fish, nuts, vegetables, and fruits, has been shown in previous studies to lower risk of CVD.

The researchers analyzed medical and lifestyle data, including dietary habits, from an existing cohort of 780 male firefighters in the Midwest.

The firefighter group with greatest adherence to Mediterranean-style diet showed a 35 percent decreased risk in metabolic syndrome, a condition with risk factors that include a large waistline, high triglyceride level, low HDL ("good") cholesterol level, high blood pressure, and high blood sugar.

The group with the highest mMDS also had a 43 percent lower risk of weight gain compared with the lowest mMDS group. Additionally, greater adherence to a Mediterranean-style diet was significantly associated with higher HDL cholesterol and lower LDL ("bad") cholesterol.

The study was published in the journal PLOS ONE.

Feb 05
High BP spreading quickly across the world
It is important for governments and aid agencies to quickly understand the risks related to high blood pressure (hypertension) as the lifestyle disease is fast spreading across the globe like HIV/AIDS once spread, says research.

The response of most governments and international aid agencies to high blood pressure (hypertension) is little better than the reaction to HIV/AIDS 20 years ago - too little too late.

"Valuable lessons for hypertension could be taken from HIV/AIDS policies. Yet there is little indication that these are being taken on board. Can we not wake up earlier this time before millions have died?" said an alarming paper jointly written by professors Peter Lloyd-Sherlock of University of East Anglia's school of international development and Shah Ebrahim and Heiner Grosskurth of the London School of Hygiene and Tropical Medicine (LSHTM).

HIV is a major global health priority and is recognised as a serious threat to public health and development in many poorer countries.

Hypertension is seen as a disease of the West, of prosperity and, therefore, of little relevance to poorer countries.

"This is despite the growing body of evidence that prevalences in poorer countries are quickly catching up," said Lloyd-Sherlock.

While hypertension is not an infectious disease, the risky behaviours associated with it are spreading fast and seem to be as effectively transmitted as infectious agents, the researchers cautioned.

HIV was faced with political denial and public misunderstanding in the early years of the pandemic, especially in some poorer countries. There is a similar pattern of denial with hypertension.

This denial is based on the misguided view that hypertension does not affect poorer social groups.

"Yet there is substantial evidence that hypertension is highly prevalent among poorer groups and that they are less likely to have access to effective treatment. As with HIV, hypertension can be both a cause and a consequence of poverty," explained the authors.

"Rather than framing policy as a choice between competing priorities, the key challenge is to roll out services and interventions which address both," added Ebrahim in the paper that appeared in the International Journal of Epidemiology.

It is estimated that the number of deaths attributable to hypertension globally over the next 20 years may substantially exceed the number resulting from HIV/AIDS.

Yet the researchers say there is 'denial' and misunderstanding about the impact of hypertension, despite the two conditions having a number of things in common.

Both diseases can also be treated and managed as chronic conditions through a combination of drug treatment and lifestyle changes.

Feb 05
Genetic function that could pave way for cancer therapies discovered
A team of researchers has discovered a genetic function that helps one of the most important "tumour suppressor" genes to do its job and prevent cancer.

According to scientists from OSU and Oregon Health and Science University, finding ways to maintain or increase the effectiveness of this gene - called Grp1-associated scaffold protein, or Grasp - could offer an important new avenue for human cancer therapies.

The Grasp gene was studied in the skin of mice in this research, but is actually expressed at the highest levels in the brain, heart and lung, studies have shown. It appears to play a fundamental role in the operation of the p53 tumour suppressor gene, which is a focus of much modern cancer research.

The new study has found that the Grasp gene is significantly involved in maintaining the proper function of p53. When "Grasp" is not being adequately expressed, the p53 protein that has entered the cell nucleus to either repair or destroy the cell comes back out of the nucleus before its work is finished.

"It appears that a primary function of Grasp is to form sort of a halo around the nucleus of a damaged skin cell, and act as kind of a plug to keep the p53 cell inside the nucleus until its work is done," one of the lead authors of this study Mark Leid said.

"A drug that could enhance Grasp function might also help enhance the p53 function, and give us a different way to keep this important tumour suppressor working the way that it is supposed to," the researcher added.

The study was published in the journal Photochemical and Photobiological Sciences.

Browse Archive